Skip to main content
Log in

Challenges in the Management of Acute Mastoiditis in Children

  • Pediatric Infectious Diseases (I Brook, Section Editor)
  • Published:
Current Infectious Disease Reports Aims and scope Submit manuscript

Abstract

Acute mastoiditis (AM) is a rare but serious complication of otitis media. Recent studies consolidated the role of Streptococcus pyogenes as the second most important etiologic agent of AM and suggested an increased involvement of a relatively new pathogen (Fusobacterium necrophorum). The recently accumulated evidence on AM epidemiology in children is conflicting and not convincing in demonstrating clear trends during the last years. While a significant decrease was recorded in the incidence of pneumococcal invasive disease and complicated AOM following the introduction of the pneumococcal conjugate vaccines, data on the efficacy of these vaccines in the prevention of AM are limited and did not show any remarkable changes in the dynamics of disease caused by Streptococcus pneumoniae. The clinical findings in AM may differ according to the causative pathogen and different patient age subgroups. Together with computerized tomography, magnetic resonance imaging became frequently used, particularly in the diagnosis of AM complications. Simple mastoidectomy remains the most reliable and effective surgical intervention for the treatment of subperiosteal abscesses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. House H. Acute otitis media. A comparative study of the results obtained in therapy before and after the introduction of the sulfonamide compounds. Arch Otolaryngol Head Neck Surg. 1946;43:371–8.

    Article  CAS  Google Scholar 

  2. Bluestone C, Klein J. Intratemporal complications and sequelae of otitis media. In: Bluestone C, Stool S, Kenna M, editors. Pediatric otolaryngology, vol. 2. 3rd ed. Philadelphia: W. B. Saunders; 1996. p. 618–23.

    Google Scholar 

  3. Spratley J, Silveira H, Alvarez I, Pais-Clemente M. Acute mastoiditis in children: review of the current status. Int J Pediatr Otorhinolaryngol. 2000;56:33–40.

    Article  CAS  PubMed  Google Scholar 

  4. Van Zuijlen DA, Schilder AG, Van Balen FA, et al. National differences in incidence of acute mastoiditis: relationship to prescribing patterns of antibiotics for acute otitis media? Pediatr Infect Dis J. 2001;20:140–4.

    Article  PubMed  Google Scholar 

  5. Katz A, Leibovitz E, Greenberg D, et al. Acute mastoiditis in Southern Israel: a twelve year retrospective study (1990 through 2001). Pediatr Infect Dis J. 2003;22:878–82.

    Article  PubMed  Google Scholar 

  6. Nussinovich M, Yoeli R, Elishkevitz K, Varsano I. Acute mastoiditis in children: epidemiologic, clinical, microbiologic, and therapeutic aspects over past years. Clin Pediatr. 2004;43:261–7.

    Article  Google Scholar 

  7. Zapalac JS, Billings KR, Schwade ND, et al. Suppurative complications of acute otitis media in the era of antibiotic resistance. Arch Otolaryngol Head Neck Surg. 2002;128:660–3.

    Article  PubMed  Google Scholar 

  8. Van Den Aardweg M, Rovers MM, de Alexander Ru J, Albers FWJ, Schilder AGM. A systematic review of diagnostic criteria for acute mastoiditis in children. Otol Neurotol. 2008;29:751–7.

    Article  PubMed  Google Scholar 

  9. Bahadori RS, Schwartz RH, Ziai M. Acute mastoiditis in children: an increase in frequency in Northern Virginia. Pediatr Infect Dis J. 2000;19:212–5.

    Article  CAS  PubMed  Google Scholar 

  10. Ghaffar FA, Wordemann M, McCracken Jr GH. Acute mastoiditis in children: a seventeen-year experience in Dallas, Texas. Pediatr Infect Dis J. 2001;20:376–80.

    Article  CAS  PubMed  Google Scholar 

  11. Benito MB, Perez Gorricho B. Acute mastoiditis: increase in the incidence and complications. Int J Pediatr Otorhinolaryngol. 2007;71:1007–11.

    Article  PubMed  Google Scholar 

  12. Amir AZ, Pomp R, Amir J. Changes in acute mastoiditis in a single pediatric tertiary medical center: our experience during 2008–2009 compared with data for 1983–2007. Scand J Infect Dis. 2014;46:9–13. Single tertiary-center study performed during 2008–2009 (and compared with 3 previous time periods) enrolling 134 children with AM and reporting S. pyogenes as the second etiologic pathogen in frequency (following S. pneumoniae).

    Article  PubMed  Google Scholar 

  13. Glatstein M, Morag S, Scolnik S, Alper A, Reif S, Grisaru-Soen G. Acute mastoiditis before pneumococcal vaccination: the experience of a large tertiary care pediatric hospital. Am J Ther. 2014. doi:10.1097/MJT.0000000000000097.

  14. Marchisio P, Bianchini S, Villani A, et al. Diagnosis and management of acute mastoiditis in a cohort of Italian children. Expert Rev Anti-Infect Ther. 2014;12:1541–8.

    Article  CAS  PubMed  Google Scholar 

  15. Kordeluk S, Orgad R, Kraus M, et al. Acute mastoiditis in children under 15 years of age in Southern Israel following the introduction of pneumococcal conjugate vaccines: a 4-year retrospective study (2009–2012). Int J Pediatr Otorhinolaryngol. 2014;78:1599–604. The study reported no changes in overall AM incidence and also in pneumococcal AM incidence during a short post vaccination period (2009–2012).

    Article  PubMed  Google Scholar 

  16. American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics. 2004;113:1451–65.

    Article  Google Scholar 

  17. Antonelli PJ, Dhanani N, Giannoni CM, Kubilis PS. Impact of resistant pneumococcus on rates of acute mastoiditis. Otolaryngol Head Neck Surg. 1999;121:190–4.

    Article  CAS  PubMed  Google Scholar 

  18. Kaplan SL, Mason EO, Wald ER, et al. Pneumococcal mastoiditis in children. Pediatrics. 2000;106:695–9.

    Article  CAS  PubMed  Google Scholar 

  19. Thompson PL, Gilbert RE, Long PF, et al. Effect of antibiotic for otitis media on mastoiditis in children: a retrospective cohort study using the United Kingdom General Practice Research Database. Pediatrics. 2009;123:424–30.

    Article  PubMed  Google Scholar 

  20. Kvaerner KJ. Lessons learned: no increase despite clinical suspicion of acute mastoiditis. Eur Arch Otorhinolaryngol. 2009;266:653–6.

    Article  PubMed  Google Scholar 

  21. Quesnel S, Nguyen M, Pierrot S, Contencin P, Manach Y, Couloigner V. Acute mastoiditis in children: a retrospective study of 188 patients. Int J Pediatr Otorhinolaryngol. 2010;74:1388–92.

    Article  CAS  PubMed  Google Scholar 

  22. Gorphe P, de Barros A, Choussy O, Dehesdin D, Marie JP. Acute mastoiditis in children: 10 years experience in a French tertiary university referral center. Eur Arch Otorhinolaryngol. 2012;269:455–60.

    Article  CAS  PubMed  Google Scholar 

  23. Groth A, Enoksson F, Hermansson A, Hultcrantz M, Stalfors J, Stenfeldt K. Acute mastoiditis in children in Sweden 1993–2007. No increase after new guidelines. Int J Pediatr Otorhinolaryngol. 2011;75:1496–501. The records of all 577 AM cases diagnosed during 1993–2007 in Sweden were analyzed; AM was most common in children < 2 years of age but its incidence did not increase following the introduction of new guidelines in 2000 for the diagnosis and treatment of AOM.

    Article  PubMed  Google Scholar 

  24. Groth A, Enoksson F, Stalfors J, Stenfeldt K, Hultcrantz M, Hermansson A. Recurrent acute mastoiditis-a retrospective national study in Sweden. Acta Otolaryngol. 2012;132:1275–81.

    Article  PubMed  Google Scholar 

  25. Anthonsen K, Høstmark K, Hansen S, et al. Acute mastoiditis in children: a 10-year retrospective and validated multicenter study. Pediatr Infect Dis J. 2013;32:436–40. Stable AM incidence rates of AM reported in eastern Denmark (average 4.8/100,000/year in children aged 0–15 years), together with low rates (6%) of S. pneumoniae resistance to penicillin during 1998–2007.

    Article  PubMed  Google Scholar 

  26. Segal N, Givon-Lavi N, Leibovitz E, Yagupsky P, Leiberman A, Dagan R. Acute otitis media caused by Streptococcus pyogenes in children. Clin Infect Dis. 2005;41:35–41.

    Article  PubMed  Google Scholar 

  27. Butbul-Aviel Y, Miron D, Halevy R, Koren A, Sakran W. Acute mastoiditis in children: Pseudomonas aeruginosa as a leading pathogen. Int J Pediatr Otorhinolaryngol. 2003;67:277–81.

    Article  PubMed  Google Scholar 

  28. Chien JH, Chen YS, Hung IF, Hsieh KS, Wu KS, Cheng MF. Mastoiditis diagnosed by clinical symptoms and imaging studies in children: disease spectrum and evolving diagnostic challenges. J Microbiol Immunol Infect. 2012;45:377–81.

    Article  PubMed  Google Scholar 

  29. Le Monnier A, Jamet A, Carbonnelle E, et al. Fusobacterium necrophorum middle ear infections in children and related complications. Report of 25 cases and literature review. Pediatr Infect Dis J. 2008;27:613–7.

    Article  PubMed  Google Scholar 

  30. Yarden-Bilavsky H, Raveh E, Livni G, Scheuerman O, Amir J, Bilavsky E. Fusobacterium necrophorum mastoiditis in children- emerging pathogen in an old disease. Int J Pediatr Otorhinolaryngol. 2013;77:92–6.

    Article  PubMed  Google Scholar 

  31. Stalfors J, Enoksson F, Hermansson A, et al. National assessment of validity of coding of acute mastoiditis: a standardized reassessment of 1966 records. Clin Otolaryngol. 2013;38:130–5. Overdiagnosis of AM is common; of 529 records with ICD coding for AM in Sweden during 1993–2007, 397 (75%) only met the definition of AM used in the study, while 18% were not diagnosed with any type of mastoiditis after review.

    Article  CAS  PubMed  Google Scholar 

  32. Laulajainen-Hongisto A, Saat R, Lempinen L, Markkola A, Aarnisalo AA, Jero J. Bacteriology in relation to clinical findings and treatment of acute mastoiditis in children. Int J Pediatr Otorhinolaryngol. 2014;78(12):2072–2078. S. pneumoniae, especially strains with reduced susceptibility, was found to cause severe symptoms and to lead to mastoidectomy more often than other pathogens. S. pyogenes was found to cause less otalgia and P. aeruginosa affected particularly children with tympanostomy tubes and caused a less aggressive form of disease.

  33. Groth A, Enoksson F, Hultcrantz M, Stalfors J, Stenfeldt K, Hermansson A. Acute mastoiditis in children aged 0–16 years—a national study of 678 cases in Sweden comparing different age groups. Int J Pediatr Otorhinolaryngol. 2012;76:1494–500.

    Article  PubMed  Google Scholar 

  34. Stenfeldt K, Enoksson F, Stalfors J, Hultcrantz M, Hermansson A, Groth A. Infants under the age of six months with acute mastoiditis. A descriptive study of 15 years in Sweden. Int J Pediatr Otorhinolaryngol. 2014;78:119–1122.

    Article  Google Scholar 

  35. Minks DP, Porte M, Jenkins N. Acute mastoiditis—the role of radiology. Clin Radiol. 2013;68:397–405. A good article emphasizing the role of radiology in demonstrating the complications of mastoiditis, particularly the intracranial ones, which may be insidious and have fatal consequences.

    Article  CAS  PubMed  Google Scholar 

  36. Luntz M, Bartal K, Brodsky A, Shihada R. Acute mastoiditis: the role of imaging for identifying intracranial complications. Laryngoscope. 2012;122:2813–7.

    Article  PubMed  Google Scholar 

  37. Saat R, Laulajainen-Hongisto H, Mahmood G, et al. MR imaging features of acute mastoiditis and their clinical relevance. Am J Neuroradiol. 2014;36:361–7. A detailed analysis of MR findings in 31 patients with AM, correlating the radiologic findings with clinical history and outcome data.

    Article  PubMed  Google Scholar 

  38. Platzek I, Kitzler HH, Gudziol V, Laniado M, Hahn G. Magnetic resonance imaging in acute mastoiditis. Acta Radiol Short Rep. 2014;3(2):2047981614523415. The performance of MRI in 23 patients with suspected AM revealed a 100% diagnostic sensitivity, 66% specificity and 86% accuracy.

    PubMed Central  PubMed  Google Scholar 

  39. Brenner DJ, Hall EJ. Computerized tomography—an increasing source of radiation exposure. N Engl J Med. 2007;357:2277–84.

    Article  CAS  PubMed  Google Scholar 

  40. Chesney J, Black A, Choo D. What is the best practice for acute mastoiditis in children? Laryngoscope. 2013;124:1057–9. A good literature review on the current evidence regarding the best diagnostic and therapeutic practice for AM in children.

    Article  PubMed  Google Scholar 

  41. Zanetti D, Nassif N. Indications for surgery in acute mastoiditis and their complications in children. Int J Pediatr Otorhinolaryngol. 2006;70:1175–82.

    Article  PubMed  Google Scholar 

  42. Psarommatis IM, Vouduris C, Douros K, Giannakoupoulos P, Bairamis T, Carabinos C. Algorithmic management of pediatric acute mastoiditis. Int J Pediatr Otorhinolaryngol. 2012;76:791–6. An attempt to develop an algorithmic approach in order reach an uniform treatment of AM.

    Article  PubMed  Google Scholar 

  43. Psarommatis I, Giannakoupoulos P, Theodorou E, Vouduris C, Carabinos C, Tsakanikos M. Mastoid subperiosteal abscess in children: drainage or mastoidectomy? J Laryngol Otol. 2012;126:1204–8.

    Article  CAS  PubMed  Google Scholar 

  44. Zawawi F, Cardona I, Akinpelu OV, Daniel SJ. Acute mastoiditis in children with cochlear implants: is explantation required? Otolaryngol Head Neck Surg. 2014;151:394–8.

    Article  PubMed  Google Scholar 

  45. Black S, Shinefield H, Baxter R, et al. Post-licensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente. Pediatr Infect Dis J. 2004;23:485–9.

    Article  PubMed  Google Scholar 

  46. Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001;344:403–9.

    Article  CAS  PubMed  Google Scholar 

  47. Casey JR, Pichichero ME. Changes in frequency and pathogens causing acute otitis media in 1995–2003. Pediatr Infect Dis J. 2004;23:824–8.

    Article  PubMed  Google Scholar 

  48. Block SL, Hedrick CJ, Harrison CJ, et al. Community-wide vaccination with the heptavalent pneumococcal conjugate vaccine significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J. 2004;23:829–33.

    Article  PubMed  Google Scholar 

  49. Huang SS, Platt R, Rifas-Shiman SL, Pelton SI, Goldmann D, Finkelstein JA. Post- PCV-7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics. 2005;116:e408–13.

    Article  PubMed  Google Scholar 

  50. Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine-United States, 2007. MMWR Morb Mortal Wkly Rep. 2010;59:253–7.

  51. Pilishvili T, Lexau C, Farley MM, et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccines. J Infect Dis. 2010;201:32–41.

    Article  PubMed  Google Scholar 

  52. Farrell DJ, Klugmna KF, Pichichero ME. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States. Pediatr Infect Dis J. 2007;28:123–8.

    Article  Google Scholar 

  53. Pichichero ME, Casey JR. Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA. 2007;298:1772–8.

    Article  CAS  PubMed  Google Scholar 

  54. Mera R, Miller LA, Fritsche TR, Jones RN. Serotype replacement and multiple resistance in Streptococcus pneumoniae after the introduction of the conjugate pneumococcal vaccine. Microb Drug Resist. 2008;14:101–7.

    Article  CAS  PubMed  Google Scholar 

  55. Isaacman DJ, McIntosh ED, Reinert RR. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int J Infect Dis. 2010;14:e197–209.

    Article  PubMed  Google Scholar 

  56. Hsu KK, Shea KM, Stevenson AE, Pelton SI. Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001–2007. Pediatr Infect Dis J. 2010;29:289–93.

    PubMed  Google Scholar 

  57. Prymula R, Peters V, Chrobok V, et al. Pneumococcal capsular polysaccharide conjugated to protein D provide protection against otitis media caused by both Streptococcus pneumoniae and nontypeable Haemophilus influenzae: a randomized double blind efficacy study. Lancet. 2006;367:740–8.

    Article  CAS  PubMed  Google Scholar 

  58. CDC. Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children—Advisory Committee on Immunization Practices (ACIP), 2010. MMWR. 2010;59:258–61.

    Google Scholar 

  59. Grijalva CG, Pelton SI. A second-generation pneumococcal conjugate vaccine for prevention of pneumococcal disease in children. Curr Opin Pediatr. 2011;23:98–104.

    Article  PubMed Central  PubMed  Google Scholar 

  60. Ben-Shimol S, Givon-Lavi N, Leibovitz E, Raiz S, Greenberg D, Dagan R. Near-elimination of otitis media caused by 13-valent pneumococcal conjugate vaccine serotypes in Southern Israel shortly after sequential introduction of 7-valent /13-valent PCV. Clin Infect Dis. 2014;15:1724–32. Comprehensive tympanocentesis-based study on the major changes occurring in the etiology of AOM following the sequential introduction of 7-valent /13-valent PCV in Israel.

    Article  Google Scholar 

  61. Roddy MG, Glazier SS, Agrawal D. Pediatric mastoiditis in the pneumococcal conjugate vaccine era: symptom duration guides empiric antimicrobial therapy. Pediatr Emerg Care. 2007;23:779–84.

    Article  PubMed  Google Scholar 

  62. Ongkasuwan J, Valdez TA, Hulten KG, Mason EO, Kaplan SL. Pneumococcal mastoiditis in children and the emergence of multidrug-resistant serotype 19A isolate. Pediatrics. 2008;122:34–9.

    Article  PubMed  Google Scholar 

  63. Choi SS, Lander L. Pediatric acute mastoiditis in the post-pneumococcal conjugate vaccine era. Laryngoscope. 2011;121:1072–80. The article showed that the number of AM admissions did not decrease with the widespread use of PCV7 and the nonsusceptibility of S. pneumoniae to penicillin and ceftriaxone may be increasing the post-PCV7 era.

    Article  PubMed  Google Scholar 

  64. Daniel M, Gautam S, Scrivener TA, Meller C, Levin B, Curotta J. What effect has pneumococcal vaccination had on acute mastoiditis? J Laryngol Otol. 2013;127:S30–4. The authors reported a decrease in the pneumococcal mastoiditis admission rates immediately following the introduction of PCV7, followed by a subsequent return of the admission rates to pre-vaccination levels.

    Article  PubMed  Google Scholar 

  65. Giannakopoulos P, Chrysovergis A, Xirogianni A, et al. Microbiology of acute mastoiditis and complicated or refractory acute otitis media among hospitalized children in the postvaccination era. Pediatr Infect Dis J. 2014;33:111–3. In Athens, Greece, during the post-PCV7 era (2010–2011), S. pneumoniae remained the most common pathogen isolated in AM, with a predominance of the multidrug resistant serotype 19A.

    Article  PubMed  Google Scholar 

  66. Halgrimson WR, Chan KH, Abzug MJ, Perkins JN, Carosone-Link P, Simões EA. Incidence of acute mastoiditis in Colorado children in the pneumococcal conjugate vaccine era. Pediatr Infect Dis J. 2014;33:453–7. The authors reported a dynamic pattern in the incidence of AM during 1999–2008: a decrease early after PCV7 introduction (2001–2004) followed by an increase in subsequent years to pre-PCV7 levels.

    Article  PubMed  Google Scholar 

  67. Ruck RC, Eberly MD. Development of pneumoccoccal mastoiditis due to multidrug-resistant serotype 19A despite three doses of 13-valent pneumococcal vaccine. Int J Pediatr Otorhinolaryngol. 2012;76:1849–51.

    Article  PubMed  Google Scholar 

  68. Kaplan SL, Barson WJ, Ling Lin P, et al. Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2013;32:203–7.

    Article  PubMed  Google Scholar 

  69. Tamir SO, Roth Y, Dalal I, Goldfarb A, Marom T. Acute mastoiditis in the pneumococcal conjugate vaccine era. Clin Vaccine Immunol. 2014;21:1189–91.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Sofia Kordeluk, Eugene Leibovitz, and Mordechai Kraus have no relevant disclosures.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by the author.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eugene Leibovitz.

Additional information

This article is part of the Topical Collection on Pediatric Infectious Diseases

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kordeluk, S., Kraus, M. & Leibovitz, E. Challenges in the Management of Acute Mastoiditis in Children. Curr Infect Dis Rep 17, 26 (2015). https://doi.org/10.1007/s11908-015-0479-4

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11908-015-0479-4

Keywords

Navigation